The Department of Health has decided to remove Etoposide Preparation under Government-Mediated Access Price (GMAP). To learn more about the changes, you can access the full contents here.
Advisory for the Request for Inputs and Recommendations on the Proposed Amendments to the Joint Administrative Order on the Implementing Guidelines of the Price Negotiation Board
Click the title to read more about the advisory.
Removal of Methotrexate and Mitomycin Preparations in the Government Mediated Access Price (GMAP) List
The Department of Health has decided to remove several medicines under Government-Mediated Access Price (GMAP). To learn more about the changes, you can access the full contents here.
Government-Mediated Access Price (GMAP) Adjustment of Salmeterol + Fluticasone Propionate
The department of health have adjusted the price of several medicines under Government-Mediated Access Price (GMAP). To know more regarding the changes you can access the full contents here.
Government-Mediated Access Price (GMAP) Adjustment of Co-Amoxiclav, Dutasteride and Paroxetine
The department of health have adjusted the price of several medicines under Government-Mediated Access Price (GMAP). To know more regarding the changes you can access the full contents here.
Observance of the World Antimicrobial Resistance (AMR) Awareness Week (WAAW) 2023 on November 18-24, 2023
The Department of Health announces the release of the department circular in commemoration of World Antimicrobial Resistance Awareness Week (WAAW) 2023, scheduled for November 18-24, 2023. To access detailed information, kindly click the link here.
Pharmaceutical Division Citizens Charter for the Electronic Drug Price Monitoring System
The Citizens Charter for the Electronic Drug Price Monitoring System contains several steps and processes focused on certification and registration. To learn more about the Charter, please click on the link.
Removal of Metronidazole and Glibenclamide Preparations in the Government-Mediated Access Price (GMAP) List
The Department of Health has removed certain medicines from the Government-Mediated Access Price (GMAP) list. For more details on these changes, you can access the full information of the circular here.
Call for Research Proposal: Procurement of Consulting Services for the Research Study entitled “Process Evaluation and Implementation Review of Executive Order (EO) No. 104 s.2020 and EO NO. 155 s.2021
Procurement of Consulting Services for the Research Study entitled “Process Evaluation and Implementation Review of Executive Order (EO) No. 104 s.2020 and EO NO. 155 s.2021” Click here for the complete information.
Immunizing Pharmacist Certification Program for Public Health Pharmacists 2022
The Department of Health-Pharmaceutical Division (DOH-PD) in collaboration with the Philippine Pharmacists Association (PPhA) conducted a face-to-face Immunizing Pharmacist Certification Program (IPCP) for Public Health Pharmacists (PHPs) with a theme of, “Empowering Public Health Pharmacists as Frontliner in the midst of pandemic through the delivery of quality health care system for the integration of Universal Health Care.”
To read the full article, kindly click the title.